Analyst Views Diverge as Alnylam Pharmaceuticals, Inc. (ALNY) Targets $5.1B Revenue and Long-Term Growth
https://finance.yahoo.com/news/analyst-views-diverge-alnylam-pharmaceuticals-143556394.html
Analyst Upgrades Signal Renewed Growth Cycle for Edwards Lifesciences Corporation (EW)
https://finance.yahoo.com/news/analyst-upgrades-signal-renewed-growth-143557929.html
Analysts See Pipeline Catalysts Driving Teva Pharmaceutical Industries Limited (TEVA)’s 2026 Growth Despite Revenue Headwinds
https://finance.yahoo.com/news/analysts-see-pipeline-catalysts-driving-143559439.html
Analysts Lift Ratings and Price Targets as Cencora, Inc. (COR)’s Growth Story Gains Momentum
https://finance.yahoo.com/news/analysts-lift-ratings-price-targets-143600505.html
IDEXX Laboratories, Inc. (IDXX): Innovation and Seamless Leadership Transition Drive 2026 Outlook
https://finance.yahoo.com/news/idexx-laboratories-inc-idxx-innovation-143602875.html
Argenx SE – ADR (ARGX) Sentiments Bolstered on Vyvgart FDA Priority Review Milestone
https://finance.yahoo.com/news/argenx-se-adr-argx-sentiments-143603597.html
AstraZeneca PLC (AZN)’s $15B China Expansion Fuels Long-Term Growth Outlook
https://finance.yahoo.com/news/astrazeneca-plc-azn-15b-china-143605112.html
Wall Street Bullish on BeOne Medicines AG (ONC) amid Robust Pipeline Development
https://finance.yahoo.com/news/wall-street-bullish-beone-medicines-143606500.html
Is Takeda Pharmaceutical Company Limited (TAK) One of the Best Healthcare Stocks to Buy for 2026?
https://finance.yahoo.com/news/takeda-pharmaceutical-company-limited-tak-143608929.html
My 2 Favorite Stocks to Buy Right Now
https://www.fool.com/investing/2026/01/31/my-2-favorite-stocks-to-buy-right-now1/